__timestamp | Exelixis, Inc. | Opthea Limited |
---|---|---|
Wednesday, January 1, 2014 | 189101000 | 3401685 |
Thursday, January 1, 2015 | 96351000 | 4284228 |
Friday, January 1, 2016 | 95967000 | 3581295 |
Sunday, January 1, 2017 | 112171000 | 4838300 |
Monday, January 1, 2018 | 182257000 | 24891534 |
Tuesday, January 1, 2019 | 336964000 | 31347891 |
Wednesday, January 1, 2020 | 547851000 | 17480747 |
Friday, January 1, 2021 | 693716000 | 34710152 |
Saturday, January 1, 2022 | 891813000 | 108459978 |
Sunday, January 1, 2023 | 1044071000 | 181563523 |
Monday, January 1, 2024 | 910408000 | 176326321 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is key. Exelixis, Inc. and Opthea Limited are two companies that have consistently invested in research and development (R&D) to drive their growth. From 2014 to 2023, Exelixis, Inc. has shown a remarkable commitment to innovation, with R&D expenses increasing by over 450%. In contrast, Opthea Limited's R&D spending, while growing, has been more modest, with a 530% increase over the same period.
Exelixis, Inc. reached its peak R&D investment in 2023, spending nearly 1.04 billion dollars, a significant leap from its 2014 expenditure. Opthea Limited, on the other hand, saw its highest R&D spending in 2023 as well, with approximately 182 million dollars. This data highlights the strategic focus of both companies on innovation, albeit at different scales.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Opthea Limited
Research and Development Investment: Bristol-Myers Squibb Company vs Opthea Limited
Research and Development Investment: GSK plc vs Opthea Limited
argenx SE or Opthea Limited: Who Invests More in Innovation?
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and Opthea Limited
R&D Insights: How Exelixis, Inc. and CymaBay Therapeutics, Inc. Allocate Funds
Exelixis, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development Investment: Exelixis, Inc. vs Alkermes plc
R&D Insights: How Exelixis, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Grifols, S.A. vs Opthea Limited
Analyzing R&D Budgets: Opthea Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Opthea Limited vs MannKind Corporation